Do Molecular Structures of Migraine Drugs Point to a Common Cause of this Elusive Disease and Suggest Future Drug Designs? Mark J. BrinsdenIan C. Shaw Editorial Open access 20 February 2015 Pages: 1 - 5
Making the Proper Choices on Education for the Pharmaceutical Industry Carl Naraynassamy Current Opinion 21 February 2015 Pages: 7 - 10
Assessing the Arrhythmogenic Potential of New Drugs: A Guide for the Pharmaceutical Physician Prasad GunaruwanLaurence Guy Howes Review Article 20 January 2015 Pages: 11 - 16
Clinical Trials Using Mobile Health Applications Melissa A. LoPrestiMickey E. AbrahamE. Sander Connolly Jr. Original Research Article 21 February 2015 Pages: 17 - 25
Drugs in Clinical Development for Malignant Melanoma: Summary and Table Adis Profile Summary 20 February 2015 Pages: 27 - 49